Get the Stockscreener App
82.76
5.38%
-4.71
After Hours:
82.76
Glaukos Corporation stock is traded at $82.76, with a volume of 883.57K.
It is down -5.38% in the last 24 hours and down -7.37% over the past month.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
See More
Previous Close:
$87.47
Open:
$87.2
24h Volume:
883.57K
Relative Volume:
0.94
Market Cap:
$4.75B
Revenue:
$360.35M
Net Income/Loss:
$-149.57M
P/E Ratio:
-27.96
EPS:
-2.96
Net Cash Flow:
$-81.27M
1W Performance:
-11.90%
1M Performance:
-7.37%
6M Performance:
-19.91%
1Y Performance:
-34.46%
1-Day Range:
$82.53
$87.37
1-Week Range:
$82.53
$94.32
52-Week Range:
$77.10
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
Name
Glaukos Corporation
Sector
Industry
Phone
949-367-9600
Address
1 GLAUKOS WAY, ALISO VIEJO, CA
Compare GKOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
82.76 | 5.02B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-19-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Dec-02-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| May-06-24 | Upgrade | Jefferies | Hold → Buy |
| Dec-21-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-28-23 | Initiated | Truist | Buy |
| Nov-08-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-07-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-04-22 | Initiated | Needham | Buy |
| Jul-12-22 | Upgrade | Stifel | Hold → Buy |
| Feb-03-22 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-19-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-03-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-26-21 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-20-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-14-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-08-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-09-20 | Initiated | Oppenheimer | Perform |
| Nov-17-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-15-20 | Initiated | Jefferies | Hold |
| Mar-05-20 | Initiated | Citigroup | Sell |
| Feb-28-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-06-20 | Upgrade | Berenberg | Hold → Buy |
| Dec-12-19 | Downgrade | Wells Fargo | Outperform → Underperform |
| Sep-30-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-08-19 | Initiated | BTIG Research | Neutral |
| Aug-30-18 | Initiated | Berenberg | Hold |
| Aug-29-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-03-18 | Reiterated | Stifel | Hold |
| Jun-21-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-13-18 | Downgrade | Stifel | Buy → Hold |
| Mar-01-18 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-02-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Jan-06-17 | Upgrade | Stifel | Hold → Buy |
| Oct-27-16 | Initiated | Wells Fargo | Outperform |
View All
Glaukos Corporation Stock (GKOS) Latest News
Navratil, Glaukos corp officer, sells $453k in shares - Investing.com
Royal Bank of Canada Buys 115,939 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos' Pipeline And High Valuation: A Risky Hold With Long-Term Upside (NYSE:GKOS) - Seeking Alpha
Glaukos' (GKOS) Buy Rating Reiterated at BTIG Research - MarketBeat
11,497 Shares in Glaukos Corporation $GKOS Bought by Rockport Wealth LLC - MarketBeat
Polar Asset Management Partners Inc. Sells 141,719 Shares of Glaukos Corporation $GKOS - MarketBeat
Great Lakes Advisors LLC Has $10.45 Million Position in Glaukos Corporation $GKOS - MarketBeat
Cinctive Capital Management LP Has $469,000 Holdings in Glaukos Corporation $GKOS - MarketBeat
Alliancebernstein L.P. Increases Stake in Glaukos Corporation $GKOS - MarketBeat
InvestingPro’s Glaukos overvaluation call proves accurate as stock falls 41% By Investing.com - Investing.com Canada
Fred Alger Management LLC Sells 159,268 Shares of Glaukos Corporation $GKOS - MarketBeat
BTIG Reiterates 'Buy' Rating for GKOS, Maintains Price Target | - GuruFocus
Glaukos Corporation $GKOS Shares Acquired by Amundi - MarketBeat
Eventide Asset Management LLC Takes Position in Glaukos Corporation $GKOS - MarketBeat
Published on: 2025-09-08 15:03:37 - beatles.ru
Presbyopia Pipeline Analysis & Clinical Trials Assessment, 2025, DelveInsight | Visus Therapeutics, Glaukos Corporation, Cellix Bio, Orasis Pharmaceuticals, Cellix Bio - Barchart.com
Published on: 2025-09-08 22:06:15 - beatles.ru
RA Capital Management L.P. Takes Position in Glaukos Corporation $GKOS - MarketBeat
EFG Asset Management North America Corp. Sells 7,516 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Holdings Lifted by Braidwell LP - MarketBeat
Is Glaukos Corporation gaining market shareMarket Sentiment Review & Accurate Intraday Trade Tips - خودرو بانک
Published on: 2025-09-05 14:43:26 - Newser
Tools to monitor Glaukos Corporation recovery probabilityJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - Newser
Is Glaukos Corporation a speculative investmentCEO Change & Low Drawdown Trading Techniques - خودرو بانک
Intraday pattern recognizer results for Glaukos CorporationJuly 2025 Selloffs & Verified Momentum Stock Ideas - Newser
Midday Stock Roundup: Karman Holdings Jumps 12% - Orange County Business Journal
Can you recover from losses in Glaukos Corporation2025 Pullback Review & Pattern Based Trade Signal System - Newser
Brokerages Set Glaukos Corporation (NYSE:GKOS) Target Price at $127.42 - MarketBeat
Will Glaukos Corporation price bounce be sustainableJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
Relative strength of Glaukos Corporation in sector analysisJuly 2025 Patterns & Daily Profit Maximizing Tips - Newser
Does Glaukos Corporation meet Warren Buffett’s criteriaSwing Trade & Real-Time Stock Entry Alerts - خودرو بانک
Applying Elliott Wave Theory to Glaukos Corporation2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Custom strategy builders for tracking Glaukos CorporationEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser
Is Glaukos Corporation still worth holding after the dipJuly 2025 Drop Watch & Smart Allocation Stock Reports - Newser
Real time scanner hits for Glaukos Corporation explainedLong Setup & Weekly Setup with ROI Potential - Newser
Kingdon Capital Management L.L.C. Invests $7.32 Million in Glaukos Corporation $GKOS - MarketBeat
How to recover losses in Glaukos Corporation stock2025 EndofYear Setup & Safe Capital Allocation Plans - Newser
Price momentum metrics for Glaukos Corporation explainedBreakout Watch & Capital Efficient Trade Techniques - Newser
Detecting price anomalies in Glaukos Corporation with AIEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed - GlobeNewswire Inc.
Will Glaukos Corporation stock go up soonQuarterly Profit Summary & Low Risk Entry Point Tips - Newser
News impact scoring models applied to Glaukos CorporationPortfolio Return Report & Weekly Breakout Stock Alerts - Newser
Multi factor analysis applied to Glaukos Corporation2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Driehaus Capital Management LLC Raises Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos at Wells Fargo Conference: Strategic Growth and Market Expansion - Investing.com
Will Glaukos Corporation rebound enough to break even2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
What’s the MACD signal for Glaukos CorporationProduct Launch & AI Powered Market Entry Strategies - خودرو بانک
Tools to assess Glaukos Corporation’s risk profileTrade Entry Report & High Accuracy Trade Alerts - Newser
Using RSI to spot recovery in Glaukos CorporationExit Point & Weekly Watchlist for Hot Stocks - Newser
Published on: 2025-09-03 02:06:26 - Newser
Does Glaukos Corporation stock have upside surprise potentialBond Market & Community Trade Idea Sharing - خودرو بانک
Glaukos Corporation Stock (GKOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):